265 related articles for article (PubMed ID: 25140042)
1. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
Lin JC; Lin CY; Tarn WY; Li FY
RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
Gautrey HL; Tyson-Capper AJ
PLoS One; 2012; 7(12):e51497. PubMed ID: 23284704
[TBL] [Abstract][Full Text] [Related]
4. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
5. Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2β1.
Jamros MA; Aubol BE; Keshwani MM; Zhang Z; Stamm S; Adams JA
J Biol Chem; 2015 Jul; 290(28):17269-81. PubMed ID: 26013829
[TBL] [Abstract][Full Text] [Related]
6. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
7. Multi-posttranscriptional regulations lessen the repressive effect of SRPK1 on brown adipogenesis.
Lin JC
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):503-514. PubMed ID: 29474929
[TBL] [Abstract][Full Text] [Related]
8. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.
Hayes GM; Carrigan PE; Miller LJ
Cancer Res; 2007 Mar; 67(5):2072-80. PubMed ID: 17332336
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
10. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
Tyson-Capper A; Gautrey H
RNA Biol; 2018; 15(12):1448-1457. PubMed ID: 30468106
[TBL] [Abstract][Full Text] [Related]
12. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
Liang YC; Lin WC; Lin YJ; Lin JC
Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
[TBL] [Abstract][Full Text] [Related]
13. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
[TBL] [Abstract][Full Text] [Related]
14. Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma.
Hayes GM; Carrigan PE; Beck AM; Miller LJ
Cancer Res; 2006 Apr; 66(7):3819-27. PubMed ID: 16585209
[TBL] [Abstract][Full Text] [Related]
15. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
Amin EM; Oltean S; Hua J; Gammons MV; Hamdollah-Zadeh M; Welsh GI; Cheung MK; Ni L; Kase S; Rennel ES; Symonds KE; Nowak DG; Royer-Pokora B; Saleem MA; Hagiwara M; Schumacher VA; Harper SJ; Hinton DR; Bates DO; Ladomery MR
Cancer Cell; 2011 Dec; 20(6):768-80. PubMed ID: 22172722
[TBL] [Abstract][Full Text] [Related]
16. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.
Markus MA; Yang YH; Morris BJ
Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347
[TBL] [Abstract][Full Text] [Related]
19. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.
He C; Liu B; Wang HY; Wu L; Zhao G; Huang C; Liu Y; Shan B; Liu L
BMC Cancer; 2022 Oct; 22(1):1100. PubMed ID: 36303126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
